NVS - Novartis AG
This page shows which of the focused investors we track hold NVS and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2024 it was held by 5 managers with an aggregate reported value of $1.34B, which is 0.12% of the combined portfolio.
As of Q2 2024, 5 tracked institutional managers held NVS (Novartis AG) with an aggregate reported value of $1.34B — 0.12% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades NVS — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2024
- Ticker
- NVS
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Dodge & Cox - Dodge & Cox | 0.78% | Reduce -0.9% | 12,236,526 | $1.3B |
| 2 | Sarah Ketterer - Causeway Capital Management | 0.59% | Reduce -15.5% | 202,335 | $21.54M |
| 3 | Tweedy Browne Co. - Tweedy Browne Value Fund | 0.43% | Reduce -2.1% | 87,606 | $9.33M |
| 4 | Kahn Brothers Group - Kahn Brothers Group | 0.31% | Add +14.1% | 17,581 | $1.87M |
| 5 | Lee Ainslie - Maverick Capital | 0.03% | Add +297.1% | 17,038 | $1.81M |
Loading holder history for NVS…